The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses

Faraz Ahmed; David Hirschl; Kapil Wattamwar; Jaron Tepper; Lyndon Lee; Jacob Cynamon

doi:10.1016/j.jvir.2022.06.017

The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses

Faraz Ahmed, David Hirschl, Kapil Wattamwar, Jaron Tepper, Lyndon Lee, Jacob Cynamon

Radiology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The purpose of this study was to investigate the safety and effectiveness of the transfemoral transcaval (TFTC) liver biopsy technique in patients with hepatic masses with relative contraindications to percutaneous biopsy and/or mass location abutting the inferior vena cava. The medical records of 16 patients (56% men; age range, 21–88 years) who underwent TFTC biopsy of hepatic masses (ranging in diameter from 2.1 to 13.2 cm) from September 2015 to August 2021 were reviewed. Histopathologic diagnoses were made in 15 of 17 (88%) procedures. Two adverse events were noted: worsened preexisting hemobilia requiring embolization in 1 patient, and a decrease in hematocrit level in another patient, requiring only observation. In conclusion, this report showed that the TFTC technique is a relatively safe and effective method for sampling hepatic masses in select cases.

Original language	English (US)
Pages (from-to)	1230-1233
Number of pages	4
Journal	Journal of Vascular and Interventional Radiology
Volume	33
Issue number	10
DOIs	https://doi.org/10.1016/j.jvir.2022.06.017
State	Published - Oct 2022

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jvir.2022.06.017

Cite this

@article{db0aa7c13b8745ec96444567aebd972f,

title = "The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses",

abstract = "The purpose of this study was to investigate the safety and effectiveness of the transfemoral transcaval (TFTC) liver biopsy technique in patients with hepatic masses with relative contraindications to percutaneous biopsy and/or mass location abutting the inferior vena cava. The medical records of 16 patients (56% men; age range, 21–88 years) who underwent TFTC biopsy of hepatic masses (ranging in diameter from 2.1 to 13.2 cm) from September 2015 to August 2021 were reviewed. Histopathologic diagnoses were made in 15 of 17 (88%) procedures. Two adverse events were noted: worsened preexisting hemobilia requiring embolization in 1 patient, and a decrease in hematocrit level in another patient, requiring only observation. In conclusion, this report showed that the TFTC technique is a relatively safe and effective method for sampling hepatic masses in select cases.",

author = "Faraz Ahmed and David Hirschl and Kapil Wattamwar and Jaron Tepper and Lyndon Lee and Jacob Cynamon",

note = "Publisher Copyright: {\textcopyright} 2022 SIR",

year = "2022",

month = oct,

doi = "10.1016/j.jvir.2022.06.017",

language = "English (US)",

volume = "33",

pages = "1230--1233",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses

AU - Ahmed, Faraz

AU - Hirschl, David

AU - Wattamwar, Kapil

AU - Tepper, Jaron

AU - Lee, Lyndon

AU - Cynamon, Jacob

PY - 2022/10

Y1 - 2022/10

N2 - The purpose of this study was to investigate the safety and effectiveness of the transfemoral transcaval (TFTC) liver biopsy technique in patients with hepatic masses with relative contraindications to percutaneous biopsy and/or mass location abutting the inferior vena cava. The medical records of 16 patients (56% men; age range, 21–88 years) who underwent TFTC biopsy of hepatic masses (ranging in diameter from 2.1 to 13.2 cm) from September 2015 to August 2021 were reviewed. Histopathologic diagnoses were made in 15 of 17 (88%) procedures. Two adverse events were noted: worsened preexisting hemobilia requiring embolization in 1 patient, and a decrease in hematocrit level in another patient, requiring only observation. In conclusion, this report showed that the TFTC technique is a relatively safe and effective method for sampling hepatic masses in select cases.

AB - The purpose of this study was to investigate the safety and effectiveness of the transfemoral transcaval (TFTC) liver biopsy technique in patients with hepatic masses with relative contraindications to percutaneous biopsy and/or mass location abutting the inferior vena cava. The medical records of 16 patients (56% men; age range, 21–88 years) who underwent TFTC biopsy of hepatic masses (ranging in diameter from 2.1 to 13.2 cm) from September 2015 to August 2021 were reviewed. Histopathologic diagnoses were made in 15 of 17 (88%) procedures. Two adverse events were noted: worsened preexisting hemobilia requiring embolization in 1 patient, and a decrease in hematocrit level in another patient, requiring only observation. In conclusion, this report showed that the TFTC technique is a relatively safe and effective method for sampling hepatic masses in select cases.

UR - http://www.scopus.com/inward/record.url?scp=85138180538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138180538&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2022.06.017

DO - 10.1016/j.jvir.2022.06.017

M3 - Article

C2 - 36182256

AN - SCOPUS:85138180538

SN - 1051-0443

VL - 33

SP - 1230

EP - 1233

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 10

ER -

The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this